Theranostics: The Future of Radiopharmaceuticals in Personalized Cancer Care The global Radiopharmaceuticals Market is projected to experience significant growth over the next decade, with the market size valued at USD 5.0 billion in 2023 and expected to reach USD 16.6 billion by 2032. The market is forecasted to expand at a robust compound annual growth rate (CAGR) of 10.4% during the forecast period from 2024 to 2032. Rising...
0 Shares
176 Views
0 Reviews